Codiak Biosciences Inc (CDAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDAK | INVO | CYCC | ||
| Company | Codiak Biosciences Inc | Invo Bioscience Inc | Cyclacel Pharmaceuti | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.1100 | 1.0300 | 1.3200 | ||
| High | 0.1100 | 1.0981 | 1.4500 | ||
| Low | 0.0532 | 1.0300 | 1.3100 | ||
| Last | 0.0570 | 1.0357 | 1.4100 | ||
| Change | -0.0725 | +0.0557 | -0.1000 | ||
| % Change | -55.98% | +5.68% | -6.62% | ||
| Volume | 14,634,700 | 302,271 | 215,609 | ||
| 20-Day Average Volume | 4,001,600 | 12,019,800 | 246,395 | ||
| Previous Close | 0.1295 | 0.9800 | 1.5100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3831 | 1.0368 | 1.8881 | ||
| 20-Day Raw Stochastic | 0.67% | 11.79% | 9.62% | ||
| 20-Day Relative Strength | 25.80% | 48.95% | 38.33% | ||
| Weighted Alpha | -91.75 | -87.15 | -85.41 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -70.00% since 03/28/23 | -16.92% since 04/22/24 | -19.43% since 04/22/24 | ||
| Low | 0.0532 on 04/04/23 | 0.8901 on 04/25/24 | 1.3100 on 04/29/24 | ||
| High | 0.2100 on 03/30/23 | 1.4600 on 04/23/24 | 2.3499 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | -89.75% since 03/03/23 | -8.83% since 03/28/24 | -33.17% since 03/28/24 | ||
| Low | 0.0532 on 04/04/23 | 0.7000 on 04/16/24 | 1.3100 on 04/29/24 | ||
| High | 0.6200 on 03/17/23 | 3.5000 on 04/17/24 | 2.3499 on 04/24/24 | ||
| 3-Month | |||||
| %Chg | -88.93% since 01/04/23 | -1.89% since 01/29/24 | -38.16% since 01/29/24 | ||
| Low | 0.0532 on 04/04/23 | 0.7000 on 04/16/24 | 1.3100 on 04/29/24 | ||
| High | 0.9378 on 02/03/23 | 3.5000 on 04/17/24 | 3.0800 on 02/20/24 | ||
| 6-Month | |||||
| %Chg | -93.16% since 10/04/22 | -20.75% since 10/27/23 | -83.38% since 10/27/23 | ||
| Low | 0.0532 on 04/04/23 | 0.6300 on 11/09/23 | 1.3100 on 04/29/24 | ||
| High | 0.9600 on 11/02/22 | 3.5000 on 04/17/24 | 10.1220 on 11/06/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,099 | 2,688 | 1,991 | ||
| Shares Outstanding, K | 36,830 | 2,743 | 1,318 | ||
| Annual Sales | 22,940,000 | 3,020,000 | 420,000 | ||
| Annual Net Income | -37,160,000 | -8,030,000 | -22,560,000 | ||
| Last Quarter Sales | 28,000 | 1,380,000 | 30,000 | ||
| Last Quarter Net Income | -19,278,000 | -1,990,000 | -5,270,000 | ||
| 60-Month Beta | 3.71 | 1.45 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 11/03/22 | -0.70 on 11/13/23 | -6.23 on 03/19/24 | ||
| Latest Earnings Date | 05/04/23 | 05/20/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | 0.150 on 07/13/16 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/13/16 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||